Artivion | CRY - Current Assets


Artivion reported $357.52M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 357.52M 566K Mar/2026
AtriCure USD 313.69M 8.82M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Inogen USD 203.72M 594K Sep/2025
Integra LifeSciences USD 1.17B 12.47M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 461.52M 44.67M Mar/2026
Pfizer USD 42.82B 76M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Terumo JPY 861.04B 45.48B Mar/2026
Trinity Biotech USD 35.9M 382K Dec/2025